COVID-19 Pipeline Diversifies as the COVID-19 Cases Soar – GlobeNewswire

Los Angeles, USA, June 01, 2021 (GLOBE NEWSWIRE) -- COVID-19 Pipeline Diversifies as the COVID-19 Cases Soar and Demand for Effective Therapies Balloons | DelveInsight

Efforts in clinical development are being continuously made to advance toward finding safe and effective treatments and vaccines for COVID-19. After the approval of vaccines across the world, new anti-viral combinations and anti-inflammatory (including monoclonal antibodies) are under investigation.

DelveInsights COVID-19 Pipeline Insights report offers exhaustive coverage of the emerging therapy landscape in different stages of development from pre-clinical till a late-end stage, along with dormant, inactive and abandoned therapeutic agents.

The COVID-19 Pipeline reports lay down a complete picture of the ongoing clinical trials, partnerships taking place in the domain, recent happenings in space and growth prospects across the COVID-19 domain.

Some of the key highlights from the COVID-19 Pipeline report:

Request for Sample to know more about the therapies that are set to grab maximum patient pool @ COVID-19 Emerging Therapies and Forecast

A Pandemic that started in late 2019, COVID-19 has affected more than 160 million people worldwide. It is an infectious disease caused by a newly discovered coronavirus SARS-CoV-2. It affects the upper respiratory tract (sinuses, nose, and throat) or lower respiratory tract (windpipe and lungs) and spreads the same way other coronaviruses do, mainly through person-to-person contact.

For more information on emerging drugs, visit COVID-19 Pipeline Analysis

COVID-19 Pipeline Drugs

Request for Sample to know more @ COVID-19 Pipeline Analysis, Key Companies and Futuristic Trends

COVID-19 Therapeutic Assessment

The COVID-19 Pipeline report proffers detailed insights into active pipeline assets segmented by Stage, Product Type, Route of Administration, Molecule Type, Target, and Mechanism of Action.

By Product Type

By Stage

By Molecule Type

By Route of Administration

By Mechanism of Action

By Targets

Get in touch with our Business executive for Informative Business Decisions, Licensing Services and Consulting Solutions

Scope of the Report

Coverage: GlobalKey Players: Sorrento Therapeutics, Molecular Partners, Amgen, Maxwell Biosciences, Frontier Biotechnologies, Galera Therapeutics, AbbVie, Synairgen, Capricor, Kinarus, IMV, RedHill Biopharma, SAb Biotherapeutics, Adagio Therapeutics, Valneva, Novavax, Inovio Pharmaceuticals, VBI Vaccines, Rigel Pharmaceuticals, Translate Bio, Evelo Biosciences, Cocrystal Pharma, Icosavax, Atea Pharmaceuticals, NovaLead among others.Key COVID-19 Pipeline Therapies: PSC 04, Ensovibep, Otezla, MXB-009, FB-2001, GC4419, ABBV-47D11, SNG001, CAP-1002, KIN001-CV, DPX COVID 19, PTC-299, RHB-107, SAB-185, ADG20, VLA2001, NVX-CoV2373, INO-4800, VBI-2902, Fostamatinib, MRT5500, EDP-1815, CDI-45205, IVX-411, AT527, NLP21 among others.

Reach out @ COVID-19 Pipeline: Novel therapies and Emerging technologies

Table of Contents

Visit to know more of whats covered @ COVID-19 Emerging Therapies, Treatments and Ongoing Clinical Trials

Related Reports

Covid 19 Therapeutic Pipeline VaccinesDelveInsights COVID-19 (Novel Coronavirus 19) - Therapeutic Pipeline for Vaccines - 2020 report provides comprehensive insights about 50+ companies and 60+ Vaccine based products in the COVID-19 pipeline landscape.

Covid 19 Novel Coronavirus 19 Therapeutic Pipeline Vaccines Diagnostics Competitive LandscapeCompanies such as Gilead Sciences, Roche, Sanofi, Regeneron Moderna, Novavax, Medicago Inc., Altimmune, APEIRON Biologics, Inovio Pharmaceuticals and GlaxoSmithKline are a few of the players working towards developing therapies for COVID-19.

EpsteinBarr virus (EBV) MarketDelveInsights EpsteinBarr virus (EBV) Market Insights, Epidemiology, and Market Forecast2030 report offers a comprehensive analysis of epidemiology, treatments and pipeline therapies with key companies including Atara Biotherapeutics, AlloVir, Tessa Therapeutics, Viracta Therapeutics, Seagen, RAPT Therapeutics, Merck, Eutilex, Atara Biotherapeutics, Labolife, and others.

Epstein-Barr Virus-associated Post-Transplant Lymphoproliferative Disease MarketDelveInsight's "Epstein-Barr Virus-associated Post-Transplant Lymphoproliferative Disease - Market Insights, Epidemiology, and Market Forecast-2030" report.

Parainfluenza Virus Infection MarketDelveInsight's "Parainfluenza Virus Infection - Market Insights, Epidemiology, and Market Forecast-2030" report offers a comprehensive analysis of epidemiology, treatments and pipeline therapies with key companies including Novartis, Pfizer, Brazion Therapeutics, among others.Rabies Virus MarketDelveInsight's "Rabies Virus - Market Insights, Epidemiology, and Market Forecast-2030" report.

Respiratory Syncytial Virus MarketDelveInsight's "Respiratory syncytial virus (RSV) - Market Insights, Epidemiology, and Market Forecast-2030" report.

Related Posts

COVID-19: Global Pandemic

COVID-19 Vaccine Outlook and Trials

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.

For more insights, visit Pharma, Healthcare, and Biotech News

Read more:

COVID-19 Pipeline Diversifies as the COVID-19 Cases Soar - GlobeNewswire